Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Androgen receptor (AR) inhibitor
DRUG
2 trials
Sponsors
University of Colorado, Denver
, Marco Oderda
Conditions
Androgen Deprivation Therapy
Autonomic Dysfunction
High Risk Prostate Cancer
Hypertension
Prostate Cancer
Renal Disease
Phase 2
Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET
Recruiting
NCT06758882
Marco Oderda
High Risk Prostate Cancer
Start: 2024-11-25
End: 2026-06-30
Target: 94
Updated: 2025-01-06
Phase 4
Contributions to Hypertension With Androgen Deprivation Therapy
Terminated
NCT05700903
University of Colorado, Denver
Androgen Deprivation Therapy, Autonomic Dysfunction, Hypertension +2
Start: 2023-09-20
End: 2025-07-16
Updated: 2026-09-02